title: In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.
abstract: Ovarian cancer (OVC) remains the most lethal gynecological malignancy in the world due to the combined lack of early-stage diagnostics and effective therapeutic strategies. The development and application of advanced proteomics technology and new experimental models has created unique opportunities for translational studies. In this study, we investigated the ovarian cancer proteome of the chicken, an emerging experimental model of OVC that develops ovarian tumors spontaneously. Matched plasma, ovary, and oviduct tissue biospecimens derived from healthy, early-stage OVC, and late-stage OVC birds were quantitatively characterized by label-free proteomics. Over 2600 proteins were identified in this study, 348 of which were differentially expressed by more than twofold (p ≤ 0.05) in early- and late-stage ovarian tumor tissue specimens relative to healthy ovarian tissues. Several of the 348 proteins are known to be differentially regulated in human cancers including B2M, CLDN3, EPCAM, PIGR, S100A6, S100A9, S100A11, and TPD52. Of particular interest was ovostatin 2 (OVOS2), a novel 165-kDa protease inhibitor found to be strongly upregulated in chicken ovarian tumors (p = 0.0005) and matched plasma (p = 0.003). Indeed, RT-quantitative PCR and Western blot analysis demonstrated that OVOS2 mRNA and protein were also upregulated in multiple human OVC cell lines compared to normal ovarian epithelia (NOE) cells and immunohistochemical staining confirmed overexpression of OVOS2 in primary human ovarian cancers relative to non-cancerous tissues. Collectively, these data provide the first evidence for involvement of OVOS2 in the pathogenesis of both chicken and human ovarian cancer.
authors.affiliation: W.M. Keck FTMS Laboratory for Human Health Research, Department of Chemistry, North Carolina State University, 2620 Yarbrough Dr., Box 8204, Raleigh, NC, 27695, USA.
authors.forename: Angelito I
authors.initials: AI
authors.lastname: Nepomuceno
authors.forename: Huanjie
authors.initials: H
authors.lastname: Shao
authors.forename: Kai
authors.initials: K
authors.lastname: Jing
authors.forename: Yibao
authors.initials: Y
authors.lastname: Ma
authors.forename: James N
authors.initials: JN
authors.lastname: Petitte
authors.forename: Michael O
authors.initials: MO
authors.lastname: Idowu
authors.forename: David C
authors.initials: DC
authors.lastname: Muddiman
authors.forename: Xianjun
authors.initials: X
authors.lastname: Fang
authors.forename: Adam M
authors.initials: AM
authors.lastname: Hawkridge
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002645:Chickens; D002853:Chromatography, Liquid / Q000379:methods*; D017124:Conserved Sequence; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000378:metabolism*; D020543:Proteome / Q000737:chemistry* / Q000378:metabolism*; D013045:Species Specificity
chemical_list: D009363:Neoplasm Proteins; D020543:Proteome